Member Info for wozzer70

Tekcapital isn’t just a basket of companies; it's a cross-pollination engine. Look at the Guident / AI / GenIP intersection. We aren't just seeing four public engines; we are seeing a ‘tech stack’ where the IP of one enhances the valuation of the others.

This "Synergy Value" is currently priced at zero in the 8p share price. The market has not yet factored in the true value of how these companies - Guident, AI, GenIP, and Lucyd - complement and strengthen each other.

When the market starts to recognize this interconnected ecosystem, 35p will no longer be a distant target; it will be the discovery zone where the full value of Tekcapital's portfolio and its synergy is priced in.

The logic of shifting from private IP to listed liquidity is the only thing that closes the 60%+ discount to NAV. Whether that bridge is finished in February or April is a footnote in the Tekcapital (TEK) growth story.

Lucyd, Guident, SALT, GenIP - all represent growing, valuable assets that will eventually be reflected in Tekcapital’s NAV.

Logic clear. Roadmap active.

A delay in the filing may be seen as negative by some, but for long-term holders, it’s a data upgrade.

The previous filing used Q3 2025 data.

The updated filing will reflect Audited FY2025 numbers, likely capturing the commercial acceleration Guident and Lucyd have experienced in recent months.

A more robust prospectus often leads to a more stable Nasdaq entry.

We’ve seen this ‘hurry up and wait’ dynamic before with MicroSalt and GenIP. The outcome was the same: they listed.

As highlighted in yesterday’s roadmap, we’ve now passed the 17th February window without SEC effectiveness. This triggers the Standard Audit Refresh protocol.

What to expect to potentially happen today:

Price Volatility: Short-term traders who were betting on a 'binary win' last night may exit. This is noise, not a fundamental change.

RNS Watch: Look for a Corporate Update confirming the shift to FY25 audited accounts.

The Big Picture: The assets (Guident, SALT, GenIP, and Lucyd) haven’t changed. The SEC backlog is a hurdle, not a wall. Patient capital holds for the refresh

Validation: When the Market Catches Up to the Roadmap"

It’s interesting to see third-party outlets and Google searches now highlighting exactly what I’ve been posting for months: the 17th Feb 'staleness' deadline and the impact of the US backlog.

For those who followed the roadmap, this isn't a surprise—it was the plan

Standard Procedure: Missing the 45-day window is a common SEC hurdle, often due to agency backlogs rather than company issues.

Stronger Data: The next filing will include audited FY25 numbers. For a growth company like Guident, more recent data often justifies a higher IPO entry price.

The Accumulation Fact: Today’s LSE tape showed 400k+ shares bought at the 8.30p ask after the US opened. Patient capital is clearly looking past the 24-hour clock.

The roadmap to bridge the NAV gap is a marathon, not a sprint. The assets are real, the listings are coming, and the 'Institutional Logic' remains the anchor.

If we miss tonight's window, the process shifts from a launch to a refresh:

Expect a "Corporate Update" RNS on the London Stock Exchange. This typically clarifies that the IPO remains the priority but will now incorporate the FY2025 audited accounts to comply with the 45-day rule.

Audit Refresh Window: Filing the updated S-1/A usually takes 4 to 8 weeks. This delay allows Guident to include full-year 2025 revenue and any 2026 commercial milestones, which can support a more robust valuation.

Institutional Continuity: As noted in your previous posts, the "big money" logic doesn't change. The shift from private to liquid assets is still the goal; only the administrative timing shifts.

The 2:30 PM Pivot: Watching the US Window

As the London market winds down, the focus shifts entirely to the US (2:30 PM – 10:00 PM UK time). This is the final 'live' window for the current Guident filing before the 17th Feb staleness deadline.

The Two Paths from here:

Immediate Effectiveness: An 'EFFECT' notice on the SEC EDGAR system tonight triggers the Nasdaq launch.

Audit Refresh: If the clock runs out, we move to a standard FY25 audit update. This isn't a 'fail'; it’s a standard SEC procedural reset that allows Guident to bake in more recent commercial progress.

The 'Institutional Logic' I mentioned previously remains the anchor: TEK is systematically converting private IP into liquid, listed assets. Whether the Nasdaq 'unlock' happens in this batch or the next, the massive discount to NAV is the only metric that matters for the long-term.

Stalls set. Logic clear. Now we watch the US tape

The 17th February deadline is tied to SEC Rule 3-12, which governs the "staleness" of financials. If Guident's filing isn’t declared Effectiveness by the end of February 17th, it risks needing a new audit, which would delay the IPO.

For more info on this, here's the official source:

Kirkland & Ellis - 2026 SEC Filing Deadlines and Staleness Dates�

https://www.kirkland.com/publications/kirkland-alert/2026/01/2026-sec-filing-deadlines-and-staleness-dates-for-public-companies

Effectiveness must happen before the end of the 17th to keep the timeline intact

If SEC effectiveness doesn't land by Tuesday's US close, it’s a procedural delay, not a fundamental failure. Missing the 'staleness' window simply means an audit refresh to include FY25 numbers.

The Bull Case for a Delay:

Stronger Prospectus: Newer filings would likely capture more recent commercial progress, potentially supporting a higher IPO valuation.

Financial Cushion: The recent £1.5m placing ensures TEK isn't rushing; they have the runway to do this right.

The Gap: TEK still trades at a massive discount to NAV. Whether the Nasdaq 'unlock' happens this week or in 8 weeks, the logic of shifting to liquid, listed assets remains the same.

Patience is the play. The value isn't going anywhere.

The market's reaction today reflects the high-stakes "staleness" deadline for the Guident IPO on Tuesday, 17 February 2026.

The "Deadline" Logic

Under SEC rules, Guident’s current Q3 2025 financials go "stale" after 17 February.

Success Scenario (SEC Effectiveness by tomorrow): If the SEC grants effectiveness before the deadline, Guident can proceed to its Nasdaq listing (ticker: GDNT). This is viewed as a major de-risking event that could trigger a significant rerate of Tekcapital’s share price toward its reported Net Asset Value (NAV) of approximately 26p–32p.

In UK time, the window for the Guident IPO "Effectiveness" notice is roughly 2:30pm until 10:00pm on Tuesday, 17 February 2026.

#Tek may also issue an RNS Tuesday.

Staleness Trigger: If the clock strikes 10:00 PM ET on Tuesday without an effectiveness notice, the Q3 financials officially go stale. At that point, Guident must pause to audit and file their full-year 2025 results.

Key Insights:

1.85 Million Shares: Two large 925k “Unknown” block trades at 09:57 suggest heavy positioning ahead of the Guident IPO.

Repeated 150k Blocks: Systematic buying at 8.40p throughout the afternoon signals institutional interest.

Price Support: Despite the 8p placing, most trades today are transacting between 8.30p and 8.40p, showing strong support above the placing price.

The Logic:

You don’t commit £150k+ in a single session if you’re expecting a "pulled IPO" or "stale" failure. This activity points to pre-effectiveness positioning. The floor is solid, and the loading is heavy as we await the key catalyst.

The current price action is attempting to move off key support levels, if that trajectory continues, a move back to 10p levels is plausible. That multi layered resistance awaits here, the Guident effectiveness catalyst, if confirmed, will likely breakthrough these levels.

Multi resistance necklines and clustered resistance becomes the next battle grounds, as long as healthy, pullbacks should be expected at each key resistance level.

Technical road map

https://docs.google.com/document/d/12AXekfMiPgzH3NpokvrMCCTe8l0QNIoxjFLNspCK61w/edit?usp=drivesdk

The Final Countdown: Guident IPO Effectiveness is Key

As we enter the final "Power Window" before the 17 February deadline, the SEC’s Effectiveness notice is the key catalyst for Tekcapital (TEK).

The Rerate: Effectiveness unlocks the real-time value of Tekcapital’s stake in Guident, bridging the gap to NAV.

Monetisation Path: Guident’s IPO opens the door to future value, positioning Tek for long-term growth.

Institutional Visibility: A successful listing increases institutional access, strengthening Tekcapital’s position.

We’re close - let’s see how the next few days unfold. DYOR

If the SEC does not declare Guident’s registration Effective by the close of business on Tuesday, 17 February, the company will likely need to refresh its financials. This means:

Re-Audit Requirement: The SEC requires updated financials, and Guident would need to perform a new audit to align with the current fiscal year (2025).

Timeline Delay: This would delay the IPO process by several weeks or even months, pushing back the anticipated Nasdaq listing.

Impact on Tekcapital (TEK): This delay would stall the potential rerate of Tekcapital’s NAV, as the market would lose the immediate clarity on Guident’s valuation post-listing.

Bottom Line: While this situation would delay the catalyst, it wouldn’t derail the core value of Tekcapital. The long-term thesis remains intact, with or without the delay, but the timing would be pushed out.

Verified Links & Source

Kirkland & Ellis 2026 Staleness Calendar: This official alert explicitly lists February 17, 2026, as the staleness date for Q3 2025 Financials for IPO issuers.

https://www.kirkland.com/publications/kirkland-alert/2026/01/2026-sec-filing-deadlines-and-staleness-dates-for-public-companies

RE: 17th Feb Deadline & SEC Staleness

To clarify the timeline: According to SEC Rule 3-12, Guident’s Q3 financials will go "stale" on Tuesday, 17 February. For the registration to remain valid, the SEC must declare the filing Effective by the end of the day on Tuesday. This is crucial to avoid the need for a new 2025 audit.

With Monday being a US holiday, we’re now in the final 48-hour "Power Window" for this to happen.

Source/Verifier: Deloitte DART - SEC Rule 3-12 Age of Financials

Comparison to Yesterday:

The consistency in high volume today shows that the 8p floor set on 10 February is acting as a launchpad, not a ceiling.

The Final Countdown:

We are now in the "Power Window." With the 17 February staleness deadline just days away, the market is preparing for the Form EFFECT notice. Smart money is positioning for the imminent Guident IPO, and it's clear the current trading activity reflects this strategic buildup.

The "Smart Money" Play:

Large-volume trades and block buys signal institutional hands at work, setting the stage for what could be a significant de-risking event once Effectiveness is confirmed. Timing is everything right now, and the floor has been solidified as we wait for the final catalyst.

We are now in the final countdown. Under SEC rules, Guident’s current financials go "stale" on 17 February 2026.

The Goal: SEC Effectiveness before the 17th. This clears the administrative path for the Nasdaq debut without the need for a time-consuming 2025 year-end audit refresh.

The Catalyst: Effectiveness is the ultimate de-risking event. It confirms the IPO is a "go," removes the threat of delay, and provides the structural trigger for the TEK rerate.

The Clock is Ticking. 🕰️